Highlights

KL Trader Investment Research Articles

Author: kltrader   |   Latest post: Wed, 22 Jan 2020, 1:10 PM

 

IHH Healthcare - Growth Offset by Higher Interest Expense

Author:   |    Publish date:


Uncertainty Lingers; Maintain HOLD

  • IHH HEALTHCARE's 3Q19 results were below our and market’s expectations. Operational earnings growth in 4Q could be slower given the start-up loss at Gleneagles Chengdu.
  • We reduce our FY19-21E EPS by 5-8%. Consequently, our SOTP-based Target Price is trimmed to MYR5.80 (-8%). Maintain HOLD as IHH Healthcare Share Price has already fallen 8% in 3 months, potentially pricing in the weak 3Q19 results.
  • Key downside risk may come from an unfavourable outcome of India’s court hearing in Feb 2020, which may see IHH Healthcare reversing its acquisition of 31% stake in Fortis. Prefer KPJ (KPJ MK) for the better risk-reward.

Below Expectations

  • Excluding net positive EIs (exceptional items, totalling MYR34m), 3Q19 core PATMI of MYR202m (-16% q-o-q, -35% y-o-y) brought 9M19 core PATMI to MYR631m (- 8% y-o-y), making up 66%/61% of our and street’s full-year forecasts. The shortfall was due to the recognition of MYR65m fair value loss on forward contracts (to hedge against exchange rate exposures on its net debt).

3Q19: Acquisition-led EBITDA Growth

  • On a y-o-y basis, 3Q19 revenue and EBITDA jumped 36% and 22%, based on a constant currency and excluding the MFRS 16 impact. The stronger y-o-y growth was mainly acquisition-led and partially due to organic growth at its existing hospitals.
  • Note that Fortis (acquired in Nov 2018) accounted for 14% of Group’s EBITDA in 3Q19. However, core PATMI fell 35% y-o-y due to the higher net interest expense and higher tax expense.
  • On a q-o-q basis, 3Q19 EBITDA grew 7% on better earnings from Singapore, Malaysia and India (including Fortis), which more than offset for weaker earnings from North Asia (including GHK). Turkey’s 3Q19 EBITDA was stable q-o-q.

Lower FY19-21E EPS by 5-8%

  • We lowered our FY19E EPS by 5% to reflect the fair value loss on forward contracts in 3Q19. Our FY20-21E EPS is also lowered by 8% p.a. as we reduce our EBITDA margin assumption by 1-ppt at Singapore, Malaysia and Turkey, to factor in the wage inflation as a result of increased competition for trained healthcare personnel at home markets.

Source: Maybank Kim Eng Research - 2 Dec 2019

Share this
Labels: IHH

Related Stocks

Chart Stock Name Last Change Volume 
IHH 5.82 -0.04 (0.68%) 6,286,100 

  Be the first to like this.
 


 

308  374  520  783 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 PWRWELL 0.29+0.005 
 MTOUCHE-WC 0.01-0.015 
 HSI-H8K 0.195+0.06 
 DGB 0.13-0.005 
 MTOUCHE 0.17-0.005 
 HSI-C7K 0.275-0.12 
 VC 0.075-0.01 
 SAPNRG 0.27+0.005 
 XDL-WD 0.015-0.005 
 XDL 0.16-0.005 

FEATURED POSTS

1. Leveraged & Inverse ETF CMS

TOP ARTICLES

1. Bank Negara MPC cuts OPR by 25bp to 2.75% save malaysia!!!
2. 【科技成长股】INARI AMERTRON BERHAD – One of EMS Industries Benefit from Cadence and Broadcom Collaboration. 【科技成长股】INARI AMERTRON BERHAD – Benefit from Cadence and Broadcom Collaboration. What Next?
3. China will keep buying our palm oil, Darell Leiking says save malaysia!!!
4. Dayang: Only fools will sell - Koon Yew Yin Koon Yew Yin's Blog
5. Notion Vtec Berhad – PART I - by Davidtslim: A high precision metal parts Specialist who rides on Electronic Manufacturing Services (“EMS”) Davidtslim sharing
6. 4大手套股发“灾难财” 星洲日報/投資致富‧企業故事
7. Top Glove and Supermax: Potential Beneficiaries Amid Coronavirus Outbreak KL Trader Investment Research Articles
8. 不是叫你买股 - NOTION篇,火后凤凰? 作者 JC JC
Partners & Brokers